912 related articles for article (PubMed ID: 29581043)
21. Elastic and Ultradeformable Liposomes for Transdermal Delivery of Active Pharmaceutical Ingredients (APIs).
Souto EB; Macedo AS; Dias-Ferreira J; Cano A; Zielińska A; Matos CM
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575907
[TBL] [Abstract][Full Text] [Related]
22. Elastic vesicles for transdermal drug delivery of hydrophilic drugs: a comparison of important physicochemical characteristics of different vesicle types.
Ntimenou V; Fahr A; Antimisiaris SG
J Biomed Nanotechnol; 2012 Aug; 8(4):613-23. PubMed ID: 22852471
[TBL] [Abstract][Full Text] [Related]
23. Lipid vesicular nanocarrier: Quick encapsulation efficiency determination and transcutaneous application.
Zhang Y; Ng W; Feng X; Cao F; Xu H
Int J Pharm; 2017 Jan; 516(1-2):225-230. PubMed ID: 27832955
[TBL] [Abstract][Full Text] [Related]
24. Transfersomes: self-optimizing carriers for bioactives.
Rai K; Gupta Y; Jain A; Jain SK
PDA J Pharm Sci Technol; 2008; 62(5):362-79. PubMed ID: 19055232
[TBL] [Abstract][Full Text] [Related]
25. Vesicles as tools for the modulation of skin permeability.
Dubey V; Mishra D; Nahar M; Jain NK
Expert Opin Drug Deliv; 2007 Nov; 4(6):579-93. PubMed ID: 17970662
[TBL] [Abstract][Full Text] [Related]
26. Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery.
Dubey V; Mishra D; Jain NK
Eur J Pharm Biopharm; 2007 Sep; 67(2):398-405. PubMed ID: 17452098
[TBL] [Abstract][Full Text] [Related]
27. Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route.
Lauterbach A; Müller-Goymann CC
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):152-63. PubMed ID: 26144664
[TBL] [Abstract][Full Text] [Related]
28. Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes.
Ascenso A; Raposo S; Batista C; Cardoso P; Mendes T; Praça FG; Bentley MV; Simões S
Int J Nanomedicine; 2015; 10():5837-51. PubMed ID: 26425085
[TBL] [Abstract][Full Text] [Related]
29. Comparative study of liposomes, ethosomes and transfersomes as carriers for enhancing the transdermal delivery of diflunisal: In vitro and in vivo evaluation.
Abd El-Alim SH; Kassem AA; Basha M; Salama A
Int J Pharm; 2019 May; 563():293-303. PubMed ID: 30951860
[TBL] [Abstract][Full Text] [Related]
30. Nanocarriers and their Actions to Improve Skin Permeability and Transdermal Drug Delivery.
Khan NR; Harun MS; Nawaz A; Harjoh N; Wong TW
Curr Pharm Des; 2015; 21(20):2848-66. PubMed ID: 25925113
[TBL] [Abstract][Full Text] [Related]
31. Ethosomes and Transfersomes: Principles, Perspectives and Practices.
Garg V; Singh H; Bimbrawh S; Singh SK; Gulati M; Vaidya Y; Kaur P
Curr Drug Deliv; 2017; 14(5):613-633. PubMed ID: 27199229
[TBL] [Abstract][Full Text] [Related]
32. Recent Developments in the Principles, Modification and Application Prospects of Functionalized Ethosomes for Topical Delivery.
Lu J; Guo T; Fan Y; Li Z; He Z; Yin S; Feng N
Curr Drug Deliv; 2021; 18(5):570-582. PubMed ID: 32851961
[TBL] [Abstract][Full Text] [Related]
33. Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation.
Mennini N; Cirri M; Maestrelli F; Mura P
Int J Pharm; 2016 Dec; 515(1-2):684-691. PubMed ID: 27825863
[TBL] [Abstract][Full Text] [Related]
34. Elastic liposomes for topical and transdermal drug delivery.
Benson HA
Curr Drug Deliv; 2009 Jul; 6(3):217-26. PubMed ID: 19604135
[TBL] [Abstract][Full Text] [Related]
35. Ultrasound and electric pulses for transdermal drug delivery enhancement: Ex vivo assessment of methods with in vivo oriented experimental protocols.
Zorec B; Jelenc J; Miklavčič D; Pavšelj N
Int J Pharm; 2015 Jul; 490(1-2):65-73. PubMed ID: 25987209
[TBL] [Abstract][Full Text] [Related]
36. Advancement of Lipid-Based Nanocarriers and Combination Application with Physical Penetration Technique.
Yang M; Gu Y; Tang X; Wang T; Liu J
Curr Drug Deliv; 2019; 16(4):312-324. PubMed ID: 30657039
[TBL] [Abstract][Full Text] [Related]
37. Fatty acid vesicles acting as expanding horizon for transdermal delivery.
Kumar L; Verma S; Kumar S; Prasad DN; Jain AK
Artif Cells Nanomed Biotechnol; 2017 Mar; 45(2):251-260. PubMed ID: 26890090
[TBL] [Abstract][Full Text] [Related]
38. Lipid vesicles: A versatile drug delivery platform for dermal and transdermal applications.
Chacko IA; Ghate VM; Dsouza L; Lewis SA
Colloids Surf B Biointerfaces; 2020 Nov; 195():111262. PubMed ID: 32736123
[TBL] [Abstract][Full Text] [Related]
39. Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: a new therapeutic approach for pain and inflammation.
Sharma G; Goyal H; Thakur K; Raza K; Katare OP
Drug Deliv; 2016 Oct; 23(8):3135-3145. PubMed ID: 26960815
[TBL] [Abstract][Full Text] [Related]
40. Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes.
Shen LN; Zhang YT; Wang Q; Xu L; Feng NP
Int J Pharm; 2014 Jan; 460(1-2):280-8. PubMed ID: 24269286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
